Dermatology Clinical Trials in Greenville, NC
As of June 2026, 1 paid clinical trial is recruiting for Dermatology in Greenville, North Carolina. Dermatology trials test biologics, JAK inhibitors, and novel topical therapies for psoriasis, atopic dermatitis, hidradenitis suppurativa, melanoma, and other inflammatory and oncologic skin conditions. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Dermatology
·Clear filters·↓ Download CSVAbout research studies in Greenville
Greenville has approximately 155 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Greenville
Researchers run research studies in Greenville, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| East Carolina University | Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, B Acute Lymphoblastic Leukemia | 88 |
| ECU Health Medical Center | Atrial Fibrillation, Coagulation Disorder, Endometrial Carcinoma | 5 |
| Brody School of Medicine at East Carolina University | Factor VII Deficiency, Healthy Participants, Hemophilia A | 4 |
| East Carolina University Health Medical Center | Pain, Sickle Cell Disease, Triple Negative Breast Cancer | 3 |
| Physicians East Endocrinology | Adult Growth Hormone Deficiency, Diabetes Mellitus, Type 1, Heart Failure | 3 |
| Carolina Researche | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 2 |
| East Carolina Univ-Greenville | Sickle Cell Disease, Thalassemia | 2 |
| Physicians East, PA | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Xentria Investigative Site | Pulmonary Sarcoidosis | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis | 1 |
| Bausch Health Site 010 | Ulcerative Colitis | 1 |
| Carolina Breast Imaging Specialists | Breast Cancer | 1 |
| Carolina Digestive Diseases and Endoscopy Center | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | 1 |
| Carolina Digestive Diseases and Endoscopy Center- Site Number : 8400014 | Crohn's Disease | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| ECU Brody School of Medicine | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | 1 |
| ECU Family Medicine Center | Hypertension | 1 |
| ECU Physicians Nephrology and Hypertension | Primary Membranous Nephropathy | 1 |
| East Carolina (University of North Carolina) | Sickle Cell Disease | 1 |
| East Carolina Heart Institute | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 1 |
| East Carolina University - Brody School of Medicine /ID# 242506 | Non-Hodgkin Lymphoma | 1 |
| East Carolina University - Brody School of Medicine /ID# 275770 | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 1 |
| East Carolina University - Infectious Diseases and Tropical/Travel Medicine Clinic | Bacterial Infection | 1 |
| East Carolina University / Vidant Health | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 1 |
| East Carolina University Brody Outpatient Center | Antineutrophil Cytoplasmic Antibody-associated Vasculitis | 1 |
Active & Upcoming Studies in Greenville (2026)
Recruiting trials in Greenville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (58 active studies)
- Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma · Phase 2, Phase 3 · TuHURA Biosciences, Inc.
- A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. · Phase 2 · AbbVie
Cardiovascular (15 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. · Phase 2 · AstraZeneca
Diabetes & metabolic (9 active studies)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Pediatric (5 active studies)
- The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma · Phase 2 · Wake Forest University Health Sciences
- Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit · East Carolina University
Neurology & pain (2 active studies)
- Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain · University of Pittsburgh
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG · Phase 3 · Icahn School of Medicine at Mount Sinai
Vaccines (1 active study)
- You and Me Healthy · Duke University
Mental health & behavior (1 active study)
- Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit · East Carolina University
Common conditions studied in Greenville
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Sickle Cell Disease (7 active studies). Sickle cell disease studies test gene therapies, gene editing, and new small molecules aimed at reducing pain crises and organ damage.
- Hypertension (4 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Atrial Fibrillation (3 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- B Acute Lymphoblastic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Greenville
- National Cancer Institute (NCI)
- Children's Oncology Group
- East Carolina University
- AstraZeneca
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Greenville. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Greenville
Hipa.ai aggregates every recruiting study in Greenville from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Greenville?
There are approximately 155 recruiting clinical trials in Greenville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Greenville pay participants?
Most recruiting trials in Greenville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Greenville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Greenville?
The most common conditions under active study in Greenville include Acute Myeloid Leukemia (8), Sickle Cell Disease (7), Hypertension (4), Acute Myeloid Leukemia Post Cytotoxic Therapy (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Greenville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Greenville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Greenville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Greenville?
Recruiting research sites in Greenville include East Carolina University, ECU Health Medical Center, Brody School of Medicine at East Carolina University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Greenville right now?
The largest active categories in Greenville are Cancer & tumors (58), Cardiovascular (15), Diabetes & metabolic (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.